Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proliferative Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05538208
What this trial is testing

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

Who this might be right for
Lupus Nephritis
Children's Hospital Medical Center, Cincinnati 105
Very early researchNot Yet RecruitingNCT07389499
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)Membranous NephropathyANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)+2 more
Grit Biotechnology 30
Post-approval studies (Phase 4)UnknownNCT02571842
What this trial is testing

Rituximab in Recurrent IgA Nephropathy

Who this might be right for
Recurrent IgA Nephropathy
Chulalongkorn University 30
Post-approval studies (Phase 4)Looking for participantsNCT05207358
What this trial is testing

Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
Institutul Clinic Fundeni 30
Not applicableLooking for participantsNCT02954939
What this trial is testing

The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
The University of Hong Kong 50
Testing effectiveness (Phase 2)Study completedNCT00976300
What this trial is testing

Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Institute of Rheumatology, Prague 40
Large-scale testing (Phase 3)Ended earlyNCT00430677
What this trial is testing

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Bristol-Myers Squibb 423
Post-approval studies (Phase 4)UnknownNCT05495893
What this trial is testing

MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN

Who this might be right for
Mycophenolate MofetilCyclophosphamideLupus Nephritis
Second Xiangya Hospital of Central South University 224
Testing effectiveness (Phase 2)Study completedNCT03095118
What this trial is testing

Daratumumab in Treatment of PGNMID and C3 GN

Who this might be right for
Membranoproliferative Glomerulonephritis
Fernando Fervenza 12
Large-scale testing (Phase 3)Ended earlyNCT01015456
What this trial is testing

The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
Chulalongkorn University 59
Large-scale testing (Phase 3)WithdrawnNCT00539799
What this trial is testing

Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
Cambridge University Hospitals NHS Foundation Trust 15
Not applicableStudy completedNCT01269021
What this trial is testing

An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)

Who this might be right for
IgA Nephropathy (IgAN)
Zhi-Hong Liu, M.D. 176
Testing effectiveness (Phase 2)Looking for participantsNCT07340463
What this trial is testing

The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Nanjing University School of Medicine 50
Post-approval studies (Phase 4)Study completedNCT02645565
What this trial is testing

Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Jawaharlal Institute of Postgraduate Medical Education & Research 75
Large-scale testing (Phase 3)Active Not RecruitingNCT07098897
What this trial is testing

To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
The Affiliated Hospital of Xuzhou Medical University 150
Testing effectiveness (Phase 2)Ended earlyNCT05097989
What this trial is testing

Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyIgAN+1 more
Alexion Pharmaceuticals, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT02547922
What this trial is testing

Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
AstraZeneca 147
Post-approval studies (Phase 4)Looking for participantsNCT07719140
What this trial is testing

Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)

Who this might be right for
Childhood-onset Systemic Lupus ErythematosusLupus Nephritis (LN)
Peking Union Medical College Hospital 198
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000